{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:16:19Z","timestamp":1793196979413,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.drugalcdep.2016.02.020","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T21:48:10Z","timestamp":1456350490000},"page":"298-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings"],"prefix":"10.1016","volume":"161","author":[{"given":"Jose M.","family":"Trigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Lagzdins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3731-0331","authenticated-orcid":false,"given":"Islam","family":"Gamaleddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0010","doi-asserted-by":"crossref","first-page":"e44864","DOI":"10.1371\/journal.pone.0044864","article-title":"Quantifying the clinical significance of cannabis withdrawal","volume":"7","author":"Allsop","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2011.06.003","article-title":"The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress","volume":"119","author":"Allsop","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey","volume":"2","author":"Anthony","year":"1994","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0025","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"2013"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40429-014-0011-1","article-title":"Novel pharmacologic approaches to treating cannabis use disorder","volume":"1","author":"Balter","year":"2014","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archpsyc.58.10.917","article-title":"Marijuana abstinence effects in marijuana smokers maintained in their home environment","volume":"58","author":"Budney","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1037\/0021-843X.112.3.393","article-title":"The time course and significance of cannabis withdrawal","volume":"112","author":"Budney","year":"2003","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0045","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1360-0443.1999.94913114.x","article-title":"Marijuana withdrawal among adults seeking treatment for marijuana dependence","volume":"94","author":"Budney","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/1064-1297.6.4.419","article-title":"Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers","volume":"6","author":"Budney","year":"1998","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1151\/ASCP07414","article-title":"Marijuana dependence and its treatment","volume":"4","author":"Budney","year":"2007","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms","volume":"86","author":"Budney","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0065","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jsat.2008.01.002","article-title":"Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse","volume":"35","author":"Budney","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1360-0443.2002.00029.x","article-title":"Cannabis dependence in young adults: an Australian population study","volume":"97","author":"Coffey","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0740-5472(00)00148-3","article-title":"Clinical profile of participants in a brief intervention program for cannabis use disorder","volume":"20","author":"Copeland","year":"2001","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550490500418997","article-title":"Cannabis withdrawal among non-treatment-seeking adult cannabis users","volume":"15","author":"Copersino","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0085","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.addbeh.2008.02.001","article-title":"Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence","volume":"33","author":"Cornelius","year":"2008","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.dcn.2015.04.001","article-title":"Motivational and control mechanisms underlying adolescent cannabis use disorders: a prospective study","volume":"16","author":"Cousijn","year":"2015","journal-title":"Dev. Cogn. Neursci."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0376-8716(98)00003-9","article-title":"Cannabis dependence withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders","volume":"50","author":"Crowley","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction","volume":"57","author":"D'Souza","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0105","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0110","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D'Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cpt1976193300","article-title":"Influence of cannabidiol on delta-9-tetrahydrocannabinol effects","volume":"19","author":"Dalton","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0033291700048017","article-title":"The brief symptom inventory: an introductory report","volume":"13","author":"Derogatis","year":"1983","journal-title":"Psychol. Med"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08897070802218166","article-title":"Marijuana neurobiology and treatment","volume":"29","author":"Elkashef","year":"2008","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/sleep\/4.1.93","article-title":"The St. Mary's Hospital sleep questionnaire: a study of reliability","volume":"4","author":"Ellis","year":"1981","journal-title":"Sleep"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0135","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1360-0443.2008.02221.x","article-title":"Cannabis use and later life outcomes","volume":"103","author":"Fergusson","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/pubmed\/fdv005","article-title":"Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities","volume":"38","author":"Fischer","year":"2016","journal-title":"J. Public Health (Oxf)"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimaraes","year":"1990","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0150","series-title":"Methods for Assessing the Reinforcing Properties of Abused Drugs","first-page":"489","article-title":"ARCI: measurement of euphoria and other drug effects","author":"Haertzen","year":"1987"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","volume":"197","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.npp.1300310","article-title":"Marijuana withdrawal in humans: effects of oral THC or divalproex","volume":"29","author":"Haney","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0175","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0376-8716(02)00084-4","article-title":"Effects of oral THC maintenance on smoked marijuana self-administration","volume":"67","author":"Hart","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0180","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1046\/j.1360-0443.2001.967102312.x","article-title":"Marijuana Craving Questionnaire: development and initial validation of a self-report instrument","volume":"96","author":"Heishman","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of delta 9\u2014tetrahydrocannabinol in man","volume":"28","author":"Karniol","year":"1974","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1373\/clinchem.2010.152439","article-title":"Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration","volume":"57","author":"Karschner","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0200","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00415-012-6739-4","article-title":"A double-blind, randomized, placebo-controlled, parallel-group study of THC\/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis","volume":"260","author":"Langford","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.drugalcdep.2012.10.011","article-title":"Can oral fluid cannabinoid testing monitor medication compliance and\/or cannabis smoking during oral THC and oromucosal Sativex administration?","volume":"130","author":"Lee","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1521-0391.2013.00321.x","article-title":"Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample","volume":"22","author":"Lev-Ran","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2010.12.010","article-title":"Dronabinol for the treatment of cannabis dependence: a randomized double-blind, placebo-controlled trial","volume":"116","author":"Levin","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0220","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.04.010","article-title":"Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers","volume":"111","author":"Levin","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0225","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chroma.2007.06.069","volume":"1163","author":"Lowe","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.009","article-title":"Cannabis and adolescent brain development","volume":"148","author":"Lubman","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0235","first-page":"CD008940","article-title":"Pharmacotherapies for cannabis dependence","volume":"12","author":"Marshall","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0240","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/npp.2012.14","article-title":"A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults","volume":"37","author":"Mason","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.forsciint.2014.03.004","article-title":"The detection of THC: CBD and CBN in the oral fluid of Sativex\u00ae patients using two on-site screening tests and LC\u2013MS\/MS","volume":"238","author":"Molnar","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0250","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/npp.2010.58","article-title":"Cannabidiol attenuates the appetitive effects of delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis","volume":"35","author":"Morgan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0255","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","article-title":"Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults","volume":"24","author":"Nicholson","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/10550490701525665","article-title":"Treatment of cannabis use disorders: a review of the literature","volume":"16","author":"Nordstrom","year":"2007","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0265","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","article-title":"A randomized double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex\u00ae), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis","volume":"18","author":"Novotna","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0270","doi-asserted-by":"crossref","DOI":"10.1016\/bs.irn.2016.02.005","article-title":"Screening and evaluation of medications for treating cannabis use disorder","author":"Panlilio","year":"2016","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0275","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0280","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0285","first-page":"33","article-title":"Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence","volume":"9","author":"Prud'homme","year":"2015","journal-title":"Subst. Abuse Res. Treat."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0290","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0295","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hup.1196","article-title":"A randomized double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use","volume":"26","author":"Schoedel","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0300","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00216-011-5197-7","article-title":"Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry","volume":"401","author":"Schwope","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0305","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: assessing normal drinkers\u2019 reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"Br. J. Addict."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2016.02.020_bib0310","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1360-0443.97.s01.6.x","article-title":"The Marijuana Treatment Project: rationale, design and participant characteristics","volume":"97","author":"Stephens","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0315","unstructured":"United Nations Office on Drugs and Crime, 2010. World Drug Report 2010, Vienna, Austria."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0320","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.schres.2014.04.023","article-title":"Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences","volume":"157","author":"van Gastel","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0325","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugalcdep.2004.11.001","article-title":"Cannabis withdrawal in adolescent treatment seekers","volume":"78","author":"Vandrey","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0330","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2165\/00023210-200923070-00001","article-title":"Pharmacotherapy for cannabis dependence: how close are we?","volume":"23","author":"Vandrey","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0335","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2012.08.001","article-title":"The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users","volume":"128","author":"Vandrey","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0340","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0345","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2006000400001","article-title":"Cannabidiol a cannabis sativa constituent, as an antipsychotic drug","volume":"39","author":"Zuardi","year":"2006","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.drugalcdep.2016.02.020_bib0350","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology (Berl.)"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T15:43:12Z","timestamp":1718379792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871616000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":70,"alternative-id":["S0376871616000958"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.020","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}